Your browser doesn't support javascript.
loading
Microbiome of the Aerodigestive Tract in Health and Esophageal Disease.
Hasan, Aws; Hasan, Laith K; Schnabl, Bernd; Greytak, Madeline; Yadlapati, Rena.
Afiliación
  • Hasan A; Division of Gastroenterology, UCSD Center for Esophageal Diseases, University of California, San Diego School of Medicine, 9500 Gilman Drive MC 0956, La Jolla, CA, 92093, USA.
  • Hasan LK; Tulane University School of Medicine, New Orleans, LA, USA.
  • Schnabl B; Division of Gastroenterology, UCSD Center for Esophageal Diseases, University of California, San Diego School of Medicine, 9500 Gilman Drive MC 0956, La Jolla, CA, 92093, USA.
  • Greytak M; Division of Gastroenterology, UCSD Center for Esophageal Diseases, University of California, San Diego School of Medicine, 9500 Gilman Drive MC 0956, La Jolla, CA, 92093, USA.
  • Yadlapati R; Division of Gastroenterology, UCSD Center for Esophageal Diseases, University of California, San Diego School of Medicine, 9500 Gilman Drive MC 0956, La Jolla, CA, 92093, USA. renahshah@gmail.com.
Dig Dis Sci ; 66(1): 12-18, 2021 01.
Article en En | MEDLINE | ID: mdl-33236315
The diverse human gut microbiome is comprised of approximately 40 trillion microorganisms representing up to 1000 different bacterial species. The human microbiome plays a critical role in gut epithelial health and disease susceptibility. While the interaction between gut microbiome and gastrointestinal pathology is increasingly understood, less is known about the interaction between the microbiome and the aerodigestive tract. This review of the microbiome of the aerodigestive tract in health, and alterations in microbiome across esophageal pathologies highlights important findings and areas for future research. First, microbiome profiles are distinct along the aerodigestive tract, spanning the oral cavity to the stomach. In patients with reflux-related disease such as gastro-esophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma, investigators have observed an overall increase in gram negative bacteria in the esophageal microbiome compared to healthy individuals. However, whether differences in microbiome promote disease development, or if these shifts are a consequence of disease remains unknown. Interestingly, use of proton pump inhibitor therapy is also associated with shifts in the microbiome, with distinct shifts and patterns along the aerodigestive tract. The relationship between the human gut microbiome and esophageal pathology is a ripe area for investigation, and further understanding of these pathways may promote development of novel targets in prevention and therapy for esophageal diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tracto Gastrointestinal / Enfermedades del Esófago / Microbioma Gastrointestinal / Pulmón Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Dig Dis Sci Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tracto Gastrointestinal / Enfermedades del Esófago / Microbioma Gastrointestinal / Pulmón Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Dig Dis Sci Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos